PDE Inhibitors Market Report

China PDE Inhibitors Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 25, 2022
  • PAGES：141
  • REPORT CODE：GMM1161550
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China PDE Inhibitors market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China PDE Inhibitors market. Detailed analysis of key players, along with key growth strategies adopted by PDE Inhibitors industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Pfizer

    • Anacor Pharmaceuticals

    • Chiesi Farmaceutici

    • NuSirt Biopharma

    • Omeros

    • Takeda Pharmaceuticals

    • Verona Pharma

    • Boehringer Ingelheim

    • Hanmi Science Holding

    • Otsuka

    By Type:

    • PDE5

    • PDE4

    • Viagra

    • Cialis

    • Levitra

    • Others

    By End-User:

    • Genitourinary

    • Cardiovascular Diseases

    • Neurological Diseases

    • Dermatological Disorders

    • Respiratory Diseases

    • Other Indications

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of PDE Inhibitors Market

    • 1.3 Market Segment by Type

    • 1.3.1 China PDE Inhibitors Market Size and Growth Rate of PDE5 from 2016 to 2027

    • 1.3.2 China PDE Inhibitors Market Size and Growth Rate of PDE4 from 2016 to 2027

    • 1.3.3 China PDE Inhibitors Market Size and Growth Rate of Viagra from 2016 to 2027

    • 1.3.4 China PDE Inhibitors Market Size and Growth Rate of Cialis from 2016 to 2027

    • 1.3.5 China PDE Inhibitors Market Size and Growth Rate of Levitra from 2016 to 2027

    • 1.3.6 China PDE Inhibitors Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China PDE Inhibitors Market Size and Growth Rate of Genitourinary from 2016 to 2027

    • 1.4.2 China PDE Inhibitors Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • 1.4.3 China PDE Inhibitors Market Size and Growth Rate of Neurological Diseases from 2016 to 2027

    • 1.4.4 China PDE Inhibitors Market Size and Growth Rate of Dermatological Disorders from 2016 to 2027

    • 1.4.5 China PDE Inhibitors Market Size and Growth Rate of Respiratory Diseases from 2016 to 2027

    • 1.4.6 China PDE Inhibitors Market Size and Growth Rate of Other Indications from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of PDE Inhibitors Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of PDE Inhibitors by Major Types

    • 3.4.1 Market Size and Growth Rate of PDE5

    • 3.4.2 Market Size and Growth Rate of PDE4

    • 3.4.3 Market Size and Growth Rate of Viagra

    • 3.4.4 Market Size and Growth Rate of Cialis

    • 3.4.5 Market Size and Growth Rate of Levitra

    • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of PDE Inhibitors Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of PDE Inhibitors by Major End-Users

    • 4.4.1 Market Size and Growth Rate of PDE Inhibitors in Genitourinary

    • 4.4.2 Market Size and Growth Rate of PDE Inhibitors in Cardiovascular Diseases

    • 4.4.3 Market Size and Growth Rate of PDE Inhibitors in Neurological Diseases

    • 4.4.4 Market Size and Growth Rate of PDE Inhibitors in Dermatological Disorders

    • 4.4.5 Market Size and Growth Rate of PDE Inhibitors in Respiratory Diseases

    • 4.4.6 Market Size and Growth Rate of PDE Inhibitors in Other Indications

    5 Market Analysis by Regions

    • 5.1 China PDE Inhibitors Production Analysis by Regions

    • 5.2 China PDE Inhibitors Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China PDE Inhibitors Landscape Analysis

    • 6.1 North China PDE Inhibitors Landscape Analysis by Major Types

    • 6.2 North China PDE Inhibitors Landscape Analysis by Major End-Users

    7 Central China PDE Inhibitors Landscape Analysis

    • 7.1 Central China PDE Inhibitors Landscape Analysis by Major Types

    • 7.2 Central China PDE Inhibitors Landscape Analysis by Major End-Users

    8 South China PDE Inhibitors Landscape Analysis

    • 8.1 South China PDE Inhibitors Landscape Analysis by Major Types

    • 8.2 South China PDE Inhibitors Landscape Analysis by Major End-Users

    9 East China PDE Inhibitors Landscape Analysis

    • 9.1 East China PDE Inhibitors Landscape Analysis by Major Types

    • 9.2 East China PDE Inhibitors Landscape Analysis by Major End-Users

    10 Northeast China PDE Inhibitors Landscape Analysis

    • 10.1 Northeast China PDE Inhibitors Landscape Analysis by Major Types

    • 10.2 Northeast China PDE Inhibitors Landscape Analysis by Major End-Users

    11 Southwest China PDE Inhibitors Landscape Analysis

    • 11.1 Southwest China PDE Inhibitors Landscape Analysis by Major Types

    • 11.2 Southwest China PDE Inhibitors Landscape Analysis by Major End-Users

    12 Northwest China PDE Inhibitors Landscape Analysis

    • 12.1 Northwest China PDE Inhibitors Landscape Analysis by Major Types

    • 12.2 Northwest China PDE Inhibitors Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Pfizer

      • 13.1.1 Pfizer Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Anacor Pharmaceuticals

      • 13.2.1 Anacor Pharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Chiesi Farmaceutici

      • 13.3.1 Chiesi Farmaceutici Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 NuSirt Biopharma

      • 13.4.1 NuSirt Biopharma Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Omeros

      • 13.5.1 Omeros Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Takeda Pharmaceuticals

      • 13.6.1 Takeda Pharmaceuticals Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Verona Pharma

      • 13.7.1 Verona Pharma Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Boehringer Ingelheim

      • 13.8.1 Boehringer Ingelheim Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Hanmi Science Holding

      • 13.9.1 Hanmi Science Holding Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Otsuka

      • 13.10.1 Otsuka Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China PDE Inhibitors Market Size and Growth Rate of PDE5 from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of PDE4 from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Viagra from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Cialis from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Levitra from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Genitourinary from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Neurological Diseases from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Dermatological Disorders from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Respiratory Diseases from 2016 to 2027

    • Figure China PDE Inhibitors Market Size and Growth Rate of Other Indications from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China PDE Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of PDE Inhibitors Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of PDE Inhibitors

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of PDE Inhibitors by Different Types from 2016 to 2027

    • Table Consumption Share of PDE Inhibitors by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of PDE5

    • Figure Market Size and Growth Rate of PDE4

    • Figure Market Size and Growth Rate of Viagra

    • Figure Market Size and Growth Rate of Cialis

    • Figure Market Size and Growth Rate of Levitra

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of PDE Inhibitors by Different End-Users from 2016 to 2027

    • Table Consumption Share of PDE Inhibitors by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Genitourinary

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Neurological Diseases

    • Figure Market Size and Growth Rate of Dermatological Disorders

    • Figure Market Size and Growth Rate of Respiratory Diseases

    • Figure Market Size and Growth Rate of Other Indications

    • Table China PDE Inhibitors Production by Regions

    • Table China PDE Inhibitors Production Share by Regions

    • Figure China PDE Inhibitors Production Share by Regions in 2016

    • Figure China PDE Inhibitors Production Share by Regions in 2021

    • Figure China PDE Inhibitors Production Share by Regions in 2027

    • Table China PDE Inhibitors Consumption by Regions

    • Table China PDE Inhibitors Consumption Share by Regions

    • Figure China PDE Inhibitors Consumption Share by Regions in 2016

    • Figure China PDE Inhibitors Consumption Share by Regions in 2021

    • Figure China PDE Inhibitors Consumption Share by Regions in 2027

    • Table North China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table North China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure North China PDE Inhibitors Consumption Share by Types in 2016

    • Figure North China PDE Inhibitors Consumption Share by Types in 2021

    • Figure North China PDE Inhibitors Consumption Share by Types in 2027

    • Table North China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table North China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure North China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure North China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure North China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table Central China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table Central China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure Central China PDE Inhibitors Consumption Share by Types in 2016

    • Figure Central China PDE Inhibitors Consumption Share by Types in 2021

    • Figure Central China PDE Inhibitors Consumption Share by Types in 2027

    • Table Central China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table Central China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure Central China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure Central China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure Central China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table South China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table South China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure South China PDE Inhibitors Consumption Share by Types in 2016

    • Figure South China PDE Inhibitors Consumption Share by Types in 2021

    • Figure South China PDE Inhibitors Consumption Share by Types in 2027

    • Table South China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table South China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure South China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure South China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure South China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table East China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table East China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure East China PDE Inhibitors Consumption Share by Types in 2016

    • Figure East China PDE Inhibitors Consumption Share by Types in 2021

    • Figure East China PDE Inhibitors Consumption Share by Types in 2027

    • Table East China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table East China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure East China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure East China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure East China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table Northeast China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table Northeast China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure Northeast China PDE Inhibitors Consumption Share by Types in 2016

    • Figure Northeast China PDE Inhibitors Consumption Share by Types in 2021

    • Figure Northeast China PDE Inhibitors Consumption Share by Types in 2027

    • Table Northeast China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table Northeast China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure Northeast China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure Northeast China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table Southwest China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table Southwest China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure Southwest China PDE Inhibitors Consumption Share by Types in 2016

    • Figure Southwest China PDE Inhibitors Consumption Share by Types in 2021

    • Figure Southwest China PDE Inhibitors Consumption Share by Types in 2027

    • Table Southwest China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table Southwest China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure Southwest China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure Southwest China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table Northwest China PDE Inhibitors Consumption by Types from 2016 to 2027

    • Table Northwest China PDE Inhibitors Consumption Share by Types from 2016 to 2027

    • Figure Northwest China PDE Inhibitors Consumption Share by Types in 2016

    • Figure Northwest China PDE Inhibitors Consumption Share by Types in 2021

    • Figure Northwest China PDE Inhibitors Consumption Share by Types in 2027

    • Table Northwest China PDE Inhibitors Consumption by End-Users from 2016 to 2027

    • Table Northwest China PDE Inhibitors Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China PDE Inhibitors Consumption Share by End-Users in 2016

    • Figure Northwest China PDE Inhibitors Consumption Share by End-Users in 2021

    • Figure Northwest China PDE Inhibitors Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Anacor Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anacor Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Anacor Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Anacor Pharmaceuticals

    • Table Product and Service Introduction of Anacor Pharmaceuticals

    • Table Company Profile and Development Status of Chiesi Farmaceutici

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chiesi Farmaceutici

    • Figure Sales and Growth Rate Analysis of Chiesi Farmaceutici

    • Figure Revenue and Market Share Analysis of Chiesi Farmaceutici

    • Table Product and Service Introduction of Chiesi Farmaceutici

    • Table Company Profile and Development Status of NuSirt Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuSirt Biopharma

    • Figure Sales and Growth Rate Analysis of NuSirt Biopharma

    • Figure Revenue and Market Share Analysis of NuSirt Biopharma

    • Table Product and Service Introduction of NuSirt Biopharma

    • Table Company Profile and Development Status of Omeros

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omeros

    • Figure Sales and Growth Rate Analysis of Omeros

    • Figure Revenue and Market Share Analysis of Omeros

    • Table Product and Service Introduction of Omeros

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of Verona Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Verona Pharma

    • Figure Sales and Growth Rate Analysis of Verona Pharma

    • Figure Revenue and Market Share Analysis of Verona Pharma

    • Table Product and Service Introduction of Verona Pharma

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Hanmi Science Holding

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hanmi Science Holding

    • Figure Sales and Growth Rate Analysis of Hanmi Science Holding

    • Figure Revenue and Market Share Analysis of Hanmi Science Holding

    • Table Product and Service Introduction of Hanmi Science Holding

    • Table Company Profile and Development Status of Otsuka

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka

    • Figure Sales and Growth Rate Analysis of Otsuka

    • Figure Revenue and Market Share Analysis of Otsuka

    • Table Product and Service Introduction of Otsuka


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US